Gener­ic drugs and biosim­i­lars get last-minute re­prieve from re­bates with Sen­ate tweaks to Build Back Bet­ter Act

The Sen­ate Fi­nance Com­mit­tee on Sat­ur­day re­leased the lat­est text of Pres­i­dent Joe Biden’s $2 tril­lion spend­ing pack­age, paid for at least in part with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA